We report two cases with complex partial and secondarily generalized seizures, both on oxcarbazepine and vigabatrin, with additional lamotrigine in one case. Both died in a manner resembling SUDEP, i.e. suddenly, unexpectedly,.probably following a seizure with pulmonary oedema at autopsy. Both had SIADH. A number of drugs may cause SIADH, among them carbamazepine and oxcarbazepine. A search for SIADH in patients on carbamazepine and oxcarbazepine, and in cases of sudden death in epilepsy, is recommended.
A 45year-old man, who had suffered from epilepsy since the age of 14, was admitted to The National Center for Epilepsy. He had an average of one complex partial seizure per day and one generalized tonic-clonic seizure at 3-month intervals. One year prior to admission he had status epilepticus. Aetiology was unknown, MRI was negative. He had recently lost his job because of reduced efficiency. He responded to questions with a slight delay and complained of difficulty in finding words as well as double vision. He was on vigabatrin (VGB) 3000 mg and carbamazepine (CBZ) 1400 mg daily, which he had used for years. He had a CBZ concentration of 48 pmol/l in serum. The day after admission, we changed the therapy directly from CBZ to oxcarbazepine (OCBZ) 1800 mg on suspicion of side effects of CBZ, and continued the VGB medication. He reported two complex partial seizures in 5 days, but presented no further symptoms. On the fifth day he appeared to be in a good mood. He ran 5 km in the morning and mingled with his fellow patients. He retired at 11 p.m. and was found dead at 11.30 p.m., kneeling in front of his bed with his face buried in the bedclothes. Resuscitation was unsuccessful.
Post-mortem investigation was performed 32 hours after death at The Institute of Forensic Medicine, University of Oslo. It revealed a fresh bite in his lower lip 1059-131 l/98/050419 + 02 $12.00/O and oedema of the lungs (weight 1600 g). Heart, brain and other organs were normal, with a brain weight of 1650 g. Blood samples were drawn on the day after admission and on the day of death, but electrolyte values were not available until after his death. Serum sodium was 125 mmol/l and serum potassium 4.5 mmol/l in the first sample, and 117 mmol/l and 4.7 mmol/l, respectively, in the second sample. Hyponatremia at the time of death was confirmed by post-mortem vitreous humor analyses. Serum creatinine (73 kmol/l) and urinary sodium (91 mmol/l) were both normal. There was no glycosuria and no elevation of serum transaminases. Unfortunately, potassium fluoride was added to the urine as a preservative prior to measurement of urine osmolality. However, an approximate correction for the added potassium fluoride allowed an estimate of 406 mOsm for the osmolality of the post-mortem bladder urine (306 mOsm if all potassium found in the urine was from the added potassium fluoride). An earlier urine sample was strongly hypertonic, as shown by a high measured specific weight, i.e. 1028.
Case 2
This patient was well until the age of 15 years, when an abscess in the left frontal lobe was removed surgically. From the age of 20 he had complex partial seizures and generalized motor seizures starting in his @ 1998 British Epilepsy Association right arm four to five times a month. He was treated with a series of antiepileptic drugs, and from the age of 28 years to his death at 30 years he was given lamotrigine 175 mg daily, in addition to OCBZ 1500 mg and vigabatrin 3000 mg. At the same time he started acupuncture treatment on his own initiative, followed by marked improvement. During the last 3 years of his life he reported one to two seizures per year. He was last seen alive on 1 November. He did not respond to phone calls on 2 and 3 November. On 4 November he was found dead in his home, lying prone on his bed. An autopsy was performed on 5 November at The Institute of Forensic Medicine, University of Oslo. It revealed a small wound on the inside of his lower lip, and blood in both nostrils. No signs of violence were found. There were two scars in the left frontal lobe, one corresponding to surgery, the other probably a small healed abscess, as well as pulmonary oedema. Probable date of death was 2 November.
Peripheral blood, bladder urine and vitreous humor were obtained at autopsy. Sodium and chloride in vitreous humor were 124 and 104 mmol/l, respectively, which may have been influenced by the delayed autopsy'. Urea was 5.7 mmol/l and creatinine 61 ,umol/l, i.e. normal values. The urine osmolality was elevated at 911 mOsmol/kg, with a specific gravity of 10 17. Urine sodium, potassium and chloride were 63, 170 and 50 rnmol/l, respectively, and there was no glucosuria. OCBZ concentration was 112 pmol/l, and lamotrigine 7.5 pmol/l.
DISCUSSION
At the time of death patient 1 was hyponatremic with a calculated subnormal serum osmolality of about 240 mOsm. The osmolality of appropriately diluted urine should have been below 100 mOsm, but the urine osmolality was found to be substantially higher and even above the serum osmolality value. There was no evidence that the urinary sodium loss was due to renal disease or adrenal insufficiency. Hence this case satisfies the criteria for the Syndrome of Inappropriate Secretion of Antidiuretic Hormone (SL4DH)2.
Patient 2 conforms to the same SIADH pattern. The exact level of hyponatremia in vivo could not be determined due to delayed autopsy, but the moderate reduction in sodium concentration in vitreous humor shows that his water intake was sufficient and that the high urine osmolality was due to SIADH rather than to water deficiency.
As far as we could determine, both patients died suddenly, unexpectedly, probably after a seizure with pulmonary oedema. Both would have been diagnosed as SUDEP if the concentration of electrolytes in body fluids had not been determined just before or after death. This is not routine at autopsy in suspected SUDEP, and it raises some questions: how often do we overlook SIADH in SUDEP? What is the role of SIADH in the demise? How often is hyponatremia in conjunction with CBZ/OCBZ due to SIADH?
CBZ and OCBZ and several other drugs are known to cause SIADH3. Presumably, the drugs either stimulate the release of ADH or cause inappropriate water reabsorption through a direct ADH-like effect on the kidneys. The water retention expands the extracellular volume and this increases the renal sodium loss. The ensuing hyponatremia causes net water transport into cells with a resulting increase in total body water as well as body weight and increased risk of cerebral oedema, particularly when serum sodium falls rapidly. Changeover from CBZ to OCBZ often aggravates hyponatremia'. Hyponatremia is usually asymptomatic5. Early symptoms are often vague and non-specific, such as weakness, lethargy and anorexia, easily mistaken for the less serious side effects of medication. Increased seizure frequency is reported in epilepsy when serum sodium levels sink below 125 mmol/l. These symptoms may progress to coma and death6+'. The gravity of the symptoms increases with the degree of the hyponatremia and the rate of fall in serum sodium levels. The mortality is high when serum sodium levels below 120 mmol/l develop acutely, but nearly zero when the progression is slow4.
We recommend more studies of these questions, particularly determination of serum sodium, urine sodium and osmolality in cases of suspected SUDEP. In patients on CBZ/OCBZ we recommend monitoring of serum sodium, urine sodium and osmolality as well as body weight in order to detect incipient SIADH, with restriction of fluid intake if necessary.
